Silver Book

Silver Book Fact

HVD patients knew little prior to their diagnosis

More than 2/3 of valve disease patients knew a limited amount or nothing about heart valve disease (HVD) before their diagnosis.

Report of Findings from Opinion Research among Heart Valve Disease Patients. http://www.agingresearch.org/backend/app/webroot/files/Publication/370/Research%20Opinion%20Survey%20among%20Heart%20Valve%20Patients_Final.pdf. Published 2016. Accessed October 16, 2017

Reference

Title
Report of Findings from Opinion Research among Heart Valve Disease Patients
Publication Date
Published 2016
URL
Read Full Resource

Publications

Aortic Stenosis Fact Sheet

 https://www.silverbook.org/wp-content/uploads/2017/10/AS-FS-cover.png Thumbnail

Connected Facts

Aortic Stenosis

Undertreatment of patients with sSAS

AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.

Prevalence & Incidence, Human Value

Aortic Stenosis

Detection rate of heart murmurs

More than 40% of heart murmurs — detected with a stethoscope and sometimes the first sign of heart valve disease (HVD) — are missed by family practitioners.

Prevalence & Incidence, Human Burden

Aortic Stenosis

Many cases of HVD are diagnosed during a routine physical check-up

Six in 10 patients did not have or recognize symptoms of heart valve disease (HVD) and were only diagnosed after going to their doctor for a regular check-up or a visit for something else.

Aortic Stenosis

Many Americans know nothing about HVD

Of those Americans surveyed ages 65+, 30% know nothing about heart valve disease (HVD).

Aortic Stenosis

American knowledge of HVD

A survey of Americans found that only 1 in 4 know “somewhat” or a “great deal” about heart valve disease (HVD). Forty percent know nothing about the disease.

Related Facts

  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Hospital Discharges from Heart Valve Disease in 2010*
     
  • Cost-effectiveness of TAVR in sSAS patients
    Patients with severe symptomatic aortic stenosis (sSAS) considered to be at high surgical risk who underwent transcatheter aortic valve replacement (TAVR) experienced lifetime incremental cost-effectiveness ratios of $55,090 per QALY…  
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007  
  • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
    Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…